|
English
|
正體中文
|
简体中文
|
Items with full text/Total items : 12145/12927 (94%)
Visitors : 850392
Online Users : 977
|
|
|
Loading...
|
Please use this identifier to cite or link to this item:
http://ir.nhri.org.tw/handle/3990099045/7907
|
Title: | MicroRNA-149 targets GIT1 to suppress integrin signaling and breast cancer metastasis |
Authors: | Chan, SH;Huang, WC;Chang, JW;Chang, KJ;Kuo, WH;Wang, MY;Lin, KY;Uen, YH;Hou, MF;Lin, CM;Jang, TH;Tu, CW;Lee, YR;Lee, YH;Tien, MT;Wang, LH |
Contributors: | Institute of Molecular and Genomic Medicine |
Abstract: | Metastasis is the predominant cause of death in breast cancer patients. Several lines of evidence have shown that microRNAs (miRs) can have an important role in cancer metastasis. Using isogenic pairs of low and high metastatic lines derived from a human breast cancer line, we have identified miR-149 to be a suppressor of breast cancer cell invasion and metastasis. We also identified GIT1 (G-protein-coupled receptor kinase-interacting protein 1) as a direct target of miR-149. Knockdown of GIT1 reduced migration/invasion and metastasis of highly invasive cells. Re-expression of GIT1 significantly rescued miR-149-mediated inhibition of cell migration/invasion and metastasis. Expression of miR-149 impaired fibronectin-induced focal adhesion formation and reduced phosphorylation of focal adhesion kinase and paxillin, which could be restored by re-expression of GIT1. Inhibition of GIT1 led to enhanced protein degradation of paxillin and α5β1 integrin via proteasome and lysosome pathways, respectively. Moreover, we found that GIT1 depletion in metastatic breast cancer cells greatly reduced α5β1-integrin-mediated cell adhesion to fibronectin and collagen. Low level of miR-149 and high level of GIT1 was significantly associated with advanced stages of breast cancer, as well as with lymph node metastasis. We conclude that miR-149 suppresses breast cancer cell migration/invasion and metastasis by targeting GIT1, suggesting potential applications of the miR-149-GIT1 pathway in clinical diagnosis and therapeutics. |
Date: | 2014-09 |
Relation: | Oncogene. 2014 Sep;33(36):4496-4507. |
Link to: | http://dx.doi.org/10.1038/onc.2014.10 |
JIF/Ranking 2023: | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0950-9232&DestApp=IC2JCR |
Cited Times(WOS): | https://www.webofscience.com/wos/woscc/full-record/WOS:000341158800005 |
Cited Times(Scopus): | http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84895417104 |
Appears in Collections: | [王陸海] 期刊論文
|
Files in This Item:
File |
Description |
Size | Format | |
SCP84895417104.pdf | | 4318Kb | Adobe PDF | 898 | View/Open |
|
All items in NHRI are protected by copyright, with all rights reserved.
|